# FDA Inspection 1079505 - Biotest Pharmaceuticals Corporation - February 08, 2019

Source: https://www.keypedia.com/records/fda_inspections/biotest-pharmaceuticals-corporation/0eef5a2a-288c-444b-aa2f-70c8c361702a
Source feed: FDA_Inspections

> FDA Inspection 1079505 for Biotest Pharmaceuticals Corporation on February 08, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079505
- Company Name: Biotest Pharmaceuticals Corporation
- Inspection Date: 2019-02-08
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 973246 - 2016-06-14](https://www.keypedia.com/records/fda_inspections/biotest-pharmaceuticals-corporation/6421c065-a5fd-47bb-959a-7cc0fa872bac)

Company: https://www.keypedia.com/companies/biotest-pharmaceuticals-corporation/e225b2fc-fd76-4c7d-84c0-ce6bdbf0ac20

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d